Expert Opinion on Emerging Drugs
Country
United Kingdom
Western Europe
Subject Area and Category
Medicine
└
Pharmacology
Q2
└
Pharmacology (medical)
Q2
Publisher
SJR 2025
0.908
Q2
SJR Score
H-Index
59
Citations / Doc (2yr)
3.44
Total Docs. (latest)
22
Total Citations (3yr)
308
Publication type
Journals
ISSN
14728214, 17447623
Coverage
2000-2025
Journal Rank
#5,701
Subject Categories
Pharmacology
Q2
Pharmacology (medical)
Q2
Subject Areas
Aims & Scope
Expert Opinion on Emerging Drugs (ISSN 1472-8214 [print], 1744-7623 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing structured reviews on Phase II and Phase III drugs/drug classes emerging onto the market across all therapy areas, providing expert opinion on their potential impact on the current management of specific diseases.
Abstracting & Indexing
Scopus
Google Scholar
Web of Science
Medline
Embase
Detailed Metrics
| Total Docs. (latest) | 22 |
| Total Docs. (3 years) | 96 |
| Total Refs. | 1,674 |
| Total Citations (3 years) | 308 |
| Citable Docs. (3 years) | 83 |
| Citations / Doc. (2 years) | 3.44 |
| Ref. / Doc. | 76.09 |
| % Female | 54.7% |
Metrics Visualization
Latest year data vs 3-year cumulative figures
Publication & Citation Trend
Loading trend data from Crossref...
Top 10 Most Cited Articles
Loading articles...
Frequently Asked Questions
What is the impact factor of Expert Opinion on Emerging Drugs?
The official Journal Impact Factor (JIF) is published by Clarivate in the Journal Citation Reports (JCR) and is not listed on this page. Based on SCImago data, Expert Opinion on Emerging Drugs has an SJR of 0.908 and is ranked Q2.
What is the SJR and quartile of Expert Opinion on Emerging Drugs?
Expert Opinion on Emerging Drugs has an SJR (SCImago Journal Rank) of 0.908 and its best quartile is Q2.
What is the H-index of Expert Opinion on Emerging Drugs?
The H-index of Expert Opinion on Emerging Drugs is 59, meaning 59 of its articles have each been cited at least 59 times.
Is Expert Opinion on Emerging Drugs indexed in Scopus?
Yes. Expert Opinion on Emerging Drugs is active in Scopus (Scopus Source List, August 2026).
Researcher Reviews
Write a ReviewNo reviews yet for this journal.
Be the first to share your experience!
Share Your Experience
Your review will be published after moderation. Email will not be displayed publicly.